About: Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3Kd inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3Kd inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
Sector: Healthcare
Industry: Biotechnology
Latest price: $12.16 (-2.59%)
PHAR NASDAQ Pharming Group NV
Pharming Group NV share price
Atividade de preço de PHAR
Último preço
$ 12,160
Variação (24h)
-0,32 USD (2,59%)
Volume
10.18K
Volume (média 4 sem.)
-
Abertura
$ 12,29
Variação do dia
$ 12,14 - $ 12,70
Fechamento anterior
$ 12,48
Último negócio
19 Nov, 6:25 pm GMT+0
Atrasado
19 Nov, 6:25 pm GMT+0
PHAR price performance
Atrasado
19 Nov, 6:25 pm GMT+0
PHAR details
quote.marketSignals